IMMUNE CELLS DEFECTIVE FOR SOCS1 Application WO-2022023576-A1 World Intellectual Property Organisation (WIPO) 03 Feb 2022
INHIBITOR OF SETDB1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY Application WO-2019170727-A1 World Intellectual Property Organisation (WIPO) 12 Sep 2019
IMMUNE CELLS DEFECTIVE FOR SUV39H1 Application WO-2018234370-A1 World Intellectual Property Organisation (WIPO) 27 Dec 2018